drugset / Trial / NCT07143786

Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke

NCT07143786 ↗

Phase 1/2 Not yet recruiting 38 enrolled Xuanwu Hospital, Beijing Wiseheart Co.Ltd · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A phase I/IIa clinical trial investigating the safety and preliminary efficacy of intravenous administration of human induced neural stem cell-derived exosomes for acute ischemic stroke

Timeline

Start
2025-10-01
Primary completion
2027-07-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject iNSC-EV01 Other / unclassified 5e+11 unknown Intravenous
Subject iNSC-EV01 Other / unclassified 2e+12 unknown Intravenous

Indications